View Future GrowthK+S 過去の業績過去 基準チェック /06K+Sの収益は年間平均-21.3%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間4.4% 3.5%割合で 増加しています。主要情報-21.30%収益成長率-22.23%EPS成長率Chemicals 業界の成長12.41%収益成長率3.54%株主資本利益率-22.00%ネット・マージン-29.49%次回の業績アップデート11 May 2026最近の業績更新お知らせ • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027お知らせ • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026お知らせ • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026お知らせ • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026お知らせ • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026Reported Earnings • Nov 16Third quarter 2024 earnings: EPS and revenues exceed analyst expectationsThird quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.すべての更新を表示Recent updatesお知らせ • Apr 03K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time.お知らせ • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027お知らせ • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.お知らせ • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026お知らせ • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026お知らせ • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026お知らせ • Apr 03+ 1 more updateK+S Aktiengesellschaft, Annual General Meeting, May 14, 2025K+S Aktiengesellschaft, Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time.お知らせ • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026Reported Earnings • Nov 16Third quarter 2024 earnings: EPS and revenues exceed analyst expectationsThird quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.お知らせ • Nov 15K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025お知らせ • Oct 24+ 1 more updateK+S Group Announces CFO Changes, Effective June 1, 2025K+S Group(SDFG) appointed Jens Christian Keuthen, currently Head of Legal, Tax, Regulatory Affairs, and New Business Areas at K+S, as CFO. Company appointed Chief Financial Officer Christian Meyer as the Chairman of the Board. All new appointments are effective from June 1, 2025.Price Target Changed • Sep 09Price target decreased by 7.7% to €13.25Down from €14.35, the current price target is an average from 17 analysts. New target price is 28% above last closing price of €10.38. Stock is down 41% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year.Price Target Changed • Aug 22Price target decreased by 8.1% to €13.42Down from €14.61, the current price target is an average from 17 analysts. New target price is 26% above last closing price of €10.70. Stock is down 37% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year.Reported Earnings • Aug 15Second quarter 2024 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2024 results: €0.034 loss per share (improved from €0.24 loss in 2Q 2023). Revenue: €873.8m (up 5.8% from 2Q 2023). Net loss: €6.10m (loss narrowed 87% from 2Q 2023). Revenue exceeded analyst estimates by 9.3%. Earnings per share (EPS) also surpassed analyst estimates by 10%. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • Aug 14K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025お知らせ • May 14K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025Reported Earnings • May 13First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2024 results: EPS: €0.10 (down from €1.38 in 1Q 2023). Revenue: €988.0m (down 17% from 1Q 2023). Net income: €18.6m (down 93% from 1Q 2023). Profit margin: 1.9% (down from 22% in 1Q 2023). Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) missed analyst estimates by 64%. Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year.Upcoming Dividend • May 09Upcoming dividend of €0.70 per shareEligible shareholders must have bought the stock before 15 May 2024. Payment date: 17 May 2024. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (4.9%).Declared Dividend • Mar 16Dividend of €0.70 announcedShareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.お知らせ • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025Reported Earnings • Mar 15Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 21%. Revenue is forecast to stay flat during the next 3 years compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 24+ 1 more updateK+S Aktiengesellschaft to Report Q3, 2024 Results on Nov 14, 2024K+S Aktiengesellschaft announced that they will report Q3, 2024 results at 7:00 AM, Central European Standard Time on Nov 14, 2024New Risk • Nov 15New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 56% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 56% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (16% net profit margin).お知らせ • Aug 15K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024Reported Earnings • Aug 13Second quarter 2023 earnings: EPS misses analyst expectationsSecond quarter 2023 results: €0.24 loss per share (down from €1.94 profit in 2Q 2022). Revenue: €825.8m (down 45% from 2Q 2022). Net loss: €45.3m (down 112% from profit in 2Q 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is expected to decline by 4.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.0%. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 11K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024Upcoming Dividend • May 04Upcoming dividend of €1.00 per share at 5.8% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).Reported Earnings • Mar 16Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is expected to decline by 6.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 27K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH).K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023.お知らせ • Jan 22K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months.お知らせ • Nov 13K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023Reported Earnings • Aug 13Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) missed analyst estimates by 9.0%. Over the next year, revenue is forecast to grow 20%, compared to a 1.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 12K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023Price Target Changed • Jun 24Price target increased to €31.29Up from €28.68, the current price target is an average from 14 analysts. New target price is 39% above last closing price of €22.50. Stock is up 96% over the past year. The company is forecast to post earnings per share of €8.26 for next year compared to €11.35 last year.Reported Earnings • May 13First quarter 2022 earnings: Revenues miss analyst expectationsFirst quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Revenue missed analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 46%, compared to a 6.4% growth forecast for the industry in Germany.お知らせ • May 12K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023Upcoming Dividend • May 06Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.1%).Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to €32.38, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €35.42 per share.Price Target Changed • Apr 08Price target increased to €26.21Up from €23.56, the current price target is an average from 14 analysts. New target price is 12% below last closing price of €29.66. Stock is up 257% over the past year. The company is forecast to post earnings per share of €6.06 for next year compared to €11.35 last year.Buying Opportunity • Mar 30Now 27% undervaluedOver the last 90 days, the stock is up 70%. The fair value is estimated to be €35.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings is forecast to decline by 51% per annum over the same time period.Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year.Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year.Price Target Changed • Mar 08Price target increased to €18.92Up from €17.59, the current price target is an average from 17 analysts. New target price is 19% below last closing price of €23.30. Stock is up 135% over the past year. The company is forecast to post earnings per share of €11.83 next year compared to a net loss per share of €9.88 last year.Buying Opportunity • Feb 22Now 21% undervaluedOver the last 90 days, the stock is up 24%. The fair value is estimated to be €24.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% per annum over the last 3 years. The company has become profitable over the last year.Price Target Changed • Nov 17Price target increased to €15.32Up from €14.27, the current price target is an average from 18 analysts. New target price is approximately in line with last closing price of €14.65. Stock is up 112% over the past year. The company is forecast to post earnings per share of €8.75 next year compared to a net loss per share of €9.88 last year.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020)Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Price Target Changed • Sep 20Price target increased to €12.75Up from €11.88, the current price target is an average from 17 analysts. New target price is approximately in line with last closing price of €12.82. Stock is up 142% over the past year.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance.Price Target Changed • Aug 04Price target increased to €11.88Up from €11.02, the current price target is an average from 15 analysts. New target price is approximately in line with last closing price of €12.32. Stock is up 95% over the past year.Price Target Changed • Jul 21Price target increased to €11.63Up from €10.85, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of €11.89. Stock is up 92% over the past year.Price Target Changed • Jun 15Price target increased to €10.86Up from €10.13, the current price target is an average from 16 analysts. New target price is 9.5% below last closing price of €12.00. Stock is up 85% over the past year.Reported Earnings • May 14First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 105 percentage points per year, which is a significant difference in performance.Price Target Changed • May 12Price target increased to €9.44Up from €8.80, the current price target is an average from 16 analysts. New target price is 8.2% below last closing price of €10.28. Stock is up 95% over the past year.Price Target Changed • Mar 20Price target decreased to €8.60Down from €9.33, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 54% over the past year.Price Target Changed • Mar 18Price target decreased to €8.49Down from €9.13, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 46% over the past year.Is New 90 Day High Low • Jan 05New 90-day high: €8.44The company is up 18% from its price of €7.15 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.57 per share.Is New 90 Day High Low • Nov 25New 90-day high: €7.25The company is up 14% from its price of €6.38 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.76 per share.Reported Earnings • Nov 13Third quarter 2020 earnings released: €10.26 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: €821.7m (down 9.2% from 3Q 2019). Net loss: €1.96b (loss widened €1.91b from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 132% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Nov 13Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 3,169%. Over the next year, revenue is forecast to grow 3.2%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.Price Target Changed • Oct 06Price target raised to €8.30Up from €7.58, the current price target is an average from 20 analysts. The new target price is 18% above the current share price of €7.04. As of last close, the stock is down 42% over the past year.Is New 90 Day High Low • Sep 22New 90-day low: €5.29The company is down 9.0% from its price of €5.80 on 24 June 2020. The German market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.99 per share.収支内訳K+S の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:SDF 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 253,648-1,076195030 Sep 253,640-1,699196030 Jun 253,627-1,728192031 Mar 253,6300189031 Dec 243,653-67187030 Sep 243,70226189030 Jun 243,7174185031 Mar 243,669-35187031 Dec 233,873210188030 Sep 234,383715190030 Jun 234,9721,045186031 Mar 235,6561,461185031 Dec 225,6771,508186030 Sep 225,2621,462194030 Jun 224,5382,450195031 Mar 223,6922,229180031 Dec 213,2132,134176030 Sep 212,7721,559180030 Jun 212,592-1,458178031 Mar 212,518-1,612192031 Dec 202,432-1,891197030 Sep 201,306-1,85340030 Jun 201,645-163100031 Mar 201,933-145141031 Dec 192,55027172030 Sep 194,264127361030 Jun 194,199121344031 Mar 194,13375346031 Dec 184,03942350030 Sep 183,85413537430 Jun 183,74089641831 Mar 183,6701597581131 Dec 173,6271859361730 Sep 173,5361548341630 Jun 173,4971138581631 Mar 173,488758721631 Dec 163,4571748711430 Sep 163,5083029681430 Jun 163,7123809891431 Mar 163,8945331,0111531 Dec 154,1764951,0481530 Sep 154,2034281,0341430 Jun 154,1394671,02014質の高い収益: SDFは現在利益が出ていません。利益率の向上: SDFは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: SDFは利益が出ておらず、過去 5 年間で損失は年間21.3%の割合で増加しています。成長の加速: SDFの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: SDFは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( -13.5% ) と比較することは困難です。株主資本利益率高いROE: SDFは現在利益が出ていないため、自己資本利益率 ( -22% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 17:04終値2026/05/07 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋K+S Aktiengesellschaft 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。41 アナリスト機関Stephen WilderAlliance Global PartnersKnut WollerBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity Research38 その他のアナリストを表示
お知らせ • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027
お知らせ • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026
お知らせ • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026
お知らせ • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026
お知らせ • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026
Reported Earnings • Nov 16Third quarter 2024 earnings: EPS and revenues exceed analyst expectationsThird quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 03K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026K+S Aktiengesellschaft, Annual General Meeting, May 12, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Mar 17K+S Aktiengesellschaft to Report Fiscal Year 2026 Results on Mar 11, 2027K+S Aktiengesellschaft announced that they will report fiscal year 2026 results at 7:00 AM, Central European Standard Time on Mar 11, 2027
お知らせ • Mar 13K+S Aktiengesellschaft announces Annual dividend, payable on May 15, 2026K+S Aktiengesellschaft announced Annual dividend of EUR 0.0700 per share payable on May 15, 2026, ex-date on May 13, 2026 and record date on May 14, 2026.
お知らせ • Nov 17K+S Aktiengesellschaft to Report Q3, 2026 Results on Nov 10, 2026K+S Aktiengesellschaft announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Nov 10, 2026
お知らせ • Aug 15K+S Aktiengesellschaft to Report Q2, 2026 Results on Aug 12, 2026K+S Aktiengesellschaft announced that they will report Q2, 2026 results on Aug 12, 2026
お知らせ • May 15K+S Aktiengesellschaft to Report Q1, 2026 Results on May 11, 2026K+S Aktiengesellschaft announced that they will report Q1, 2026 results on May 11, 2026
お知らせ • Apr 03+ 1 more updateK+S Aktiengesellschaft, Annual General Meeting, May 14, 2025K+S Aktiengesellschaft, Annual General Meeting, May 14, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2025 Results on Mar 12, 2026K+S Aktiengesellschaft announced that they will report fiscal year 2025 results on Mar 12, 2026
Reported Earnings • Nov 16Third quarter 2024 earnings: EPS and revenues exceed analyst expectationsThird quarter 2024 results: €0.15 loss per share (improved from €0.26 loss in 3Q 2023). Revenue: €866.2m (down 1.7% from 3Q 2023). Net loss: €26.4m (loss narrowed 45% from 3Q 2023). Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 15K+S Aktiengesellschaft to Report Q3, 2025 Results on Nov 11, 2025K+S Aktiengesellschaft announced that they will report Q3, 2025 results on Nov 11, 2025
お知らせ • Oct 24+ 1 more updateK+S Group Announces CFO Changes, Effective June 1, 2025K+S Group(SDFG) appointed Jens Christian Keuthen, currently Head of Legal, Tax, Regulatory Affairs, and New Business Areas at K+S, as CFO. Company appointed Chief Financial Officer Christian Meyer as the Chairman of the Board. All new appointments are effective from June 1, 2025.
Price Target Changed • Sep 09Price target decreased by 7.7% to €13.25Down from €14.35, the current price target is an average from 17 analysts. New target price is 28% above last closing price of €10.38. Stock is down 41% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year.
Price Target Changed • Aug 22Price target decreased by 8.1% to €13.42Down from €14.61, the current price target is an average from 17 analysts. New target price is 26% above last closing price of €10.70. Stock is down 37% over the past year. The company is forecast to post earnings per share of €0.29 for next year compared to €1.12 last year.
Reported Earnings • Aug 15Second quarter 2024 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2024 results: €0.034 loss per share (improved from €0.24 loss in 2Q 2023). Revenue: €873.8m (up 5.8% from 2Q 2023). Net loss: €6.10m (loss narrowed 87% from 2Q 2023). Revenue exceeded analyst estimates by 9.3%. Earnings per share (EPS) also surpassed analyst estimates by 10%. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • Aug 14K+S Aktiengesellschaft to Report Q2, 2025 Results on Aug 12, 2025K+S Aktiengesellschaft announced that they will report Q2, 2025 results on Aug 12, 2025
お知らせ • May 14K+S Aktiengesellschaft to Report Q1, 2025 Results on May 13, 2025K+S Aktiengesellschaft announced that they will report Q1, 2025 results on May 13, 2025
Reported Earnings • May 13First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2024 results: EPS: €0.10 (down from €1.38 in 1Q 2023). Revenue: €988.0m (down 17% from 1Q 2023). Net income: €18.6m (down 93% from 1Q 2023). Profit margin: 1.9% (down from 22% in 1Q 2023). Revenue exceeded analyst estimates by 7.1%. Earnings per share (EPS) missed analyst estimates by 64%. Revenue is forecast to grow 1.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year.
Upcoming Dividend • May 09Upcoming dividend of €0.70 per shareEligible shareholders must have bought the stock before 15 May 2024. Payment date: 17 May 2024. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 5.1%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (4.9%).
Declared Dividend • Mar 16Dividend of €0.70 announcedShareholders will receive a dividend of €0.70. Ex-date: 15th May 2024 Payment date: 17th May 2024 Dividend yield will be 5.3%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is covered by both earnings (62% earnings payout ratio) and cash flows (37% cash payout ratio). The dividend has increased by an average of 11% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to decline by 65% over the next 3 years. Since a fall of 31% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk.
お知らせ • Mar 15K+S Aktiengesellschaft to Report Fiscal Year 2024 Results on Mar 13, 2025K+S Aktiengesellschaft announced that they will report fiscal year 2024 results on Mar 13, 2025
Reported Earnings • Mar 15Full year 2023 earnings: EPS exceeds analyst expectationsFull year 2023 results: EPS: €1.12 (down from €7.88 in FY 2022). Revenue: €3.87b (down 32% from FY 2022). Net income: €209.9m (down 86% from FY 2022). Profit margin: 5.4% (down from 27% in FY 2022). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 21%. Revenue is forecast to stay flat during the next 3 years compared to a 3.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 24+ 1 more updateK+S Aktiengesellschaft to Report Q3, 2024 Results on Nov 14, 2024K+S Aktiengesellschaft announced that they will report Q3, 2024 results at 7:00 AM, Central European Standard Time on Nov 14, 2024
New Risk • Nov 15New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 56% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 56% per year for the foreseeable future. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (16% net profit margin).
お知らせ • Aug 15K+S Aktiengesellschaft to Report Q1, 2024 Results on May 13, 2024K+S Aktiengesellschaft announced that they will report Q1, 2024 results at 7:00 AM, Central European Standard Time on May 13, 2024
Reported Earnings • Aug 13Second quarter 2023 earnings: EPS misses analyst expectationsSecond quarter 2023 results: €0.24 loss per share (down from €1.94 profit in 2Q 2022). Revenue: €825.8m (down 45% from 2Q 2022). Net loss: €45.3m (down 112% from profit in 2Q 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is expected to decline by 4.1% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.0%. Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 11K+S Aktiengesellschaft to Report Q2, 2024 Results on Aug 14, 2024K+S Aktiengesellschaft announced that they will report Q2, 2024 results on Aug 14, 2024
Upcoming Dividend • May 04Upcoming dividend of €1.00 per share at 5.8% yieldEligible shareholders must have bought the stock before 11 May 2023. Payment date: 15 May 2023. Payout ratio is a comfortable 13% and this is well supported by cash flows. Trailing yield: 5.8%. Within top quartile of German dividend payers (4.7%). In line with average of industry peers (5.6%).
Reported Earnings • Mar 16Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: €7.88 (down from €11.35 in FY 2021). Revenue: €5.68b (up 77% from FY 2021). Net income: €1.51b (down 31% from FY 2021). Profit margin: 27% (down from 68% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 18%. Revenue is expected to decline by 6.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Germany are expected to grow by 2.7%. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 27K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH).K+S Aktiengesellschaft (XTRA:SDF) agreed to acquire 75% stake in Fertilizer business of Industrial Commodities Holdings (Pty) Ltd (ICH) on January 26, 2023. The new business will operate under the name Fertiva (Pty) Ltd. The balance of 25% of shares in Fertiva will be held by two former ICH shareholders, who will now be a part of the Fertiva management team. The closing of the transaction remains subject to the fulfillment of a number of conditions, including obtaining required regulatory approvals and is expected to close during the second quarter of 2023.
お知らせ • Jan 22K+S Aktiengesellschaft Appoints Carin-Martina Tröltzsch as Member of the Board of Executive Directors, Effective March 15, 2023The Supervisory Board of K+S Aktiengesellschaft has appointed Dr. Carin-Martina Tröltzsch as a further member of the Board of Executive Directors of the Company. She will assume her position at K+S on March 15, 2023. Dr. Christian H. Meyer, who was already appointed as the new Chief Financial Officer by the Supervisory Board of the Company in February of last year, will also take up his position on March 15, 2023, and will be responsible for the management and further development of the finance area at K+S. Dr. Burkhard Lohr, Chairman of the Board of Executive Directors, had assumed this role on a transitional basis in recent months.
お知らせ • Nov 13K+S Aktiengesellschaft to Report Q3, 2022 Results on Nov 14, 2023K+S Aktiengesellschaft announced that they will report Q3, 2022 results at 7:00 AM, Central European Standard Time on Nov 14, 2023
Reported Earnings • Aug 13Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindSecond quarter 2022 results: EPS: €1.93 (up from €0.78 in 2Q 2021). Revenue: €1.51b (up 127% from 2Q 2021). Net income: €370.3m (up 147% from 2Q 2021). Profit margin: 25% (up from 23% in 2Q 2021). Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) missed analyst estimates by 9.0%. Over the next year, revenue is forecast to grow 20%, compared to a 1.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 12K+S Aktiengesellschaft to Report Q2, 2023 Results on Aug 10, 2023K+S Aktiengesellschaft announced that they will report Q2, 2023 results on Aug 10, 2023
Price Target Changed • Jun 24Price target increased to €31.29Up from €28.68, the current price target is an average from 14 analysts. New target price is 39% above last closing price of €22.50. Stock is up 96% over the past year. The company is forecast to post earnings per share of €8.26 for next year compared to €11.35 last year.
Reported Earnings • May 13First quarter 2022 earnings: Revenues miss analyst expectationsFirst quarter 2022 results: Revenue: €1.21b (up 65% from 1Q 2021). Net income: €310.9m (up 44% from 1Q 2021). Profit margin: 26% (down from 29% in 1Q 2021). Revenue missed analyst estimates by 5.3%. Over the next year, revenue is forecast to grow 46%, compared to a 6.4% growth forecast for the industry in Germany.
お知らせ • May 12K+S Aktiengesellschaft to Report Q1, 2023 Results on May 09, 2023K+S Aktiengesellschaft announced that they will report Q1, 2023 results on May 09, 2023
Upcoming Dividend • May 06Upcoming dividend of €0.20 per shareEligible shareholders must have bought the stock before 13 May 2022. Payment date: 17 May 2022. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.1%).
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improved over the past weekAfter last week's 16% share price gain to €32.38, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 81% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €35.42 per share.
Price Target Changed • Apr 08Price target increased to €26.21Up from €23.56, the current price target is an average from 14 analysts. New target price is 12% below last closing price of €29.66. Stock is up 257% over the past year. The company is forecast to post earnings per share of €6.06 for next year compared to €11.35 last year.
Buying Opportunity • Mar 30Now 27% undervaluedOver the last 90 days, the stock is up 70%. The fair value is estimated to be €35.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 18% over the last 3 years. Meanwhile, the company has become profitable. For the next 3 years, revenue is forecast to grow by 4.6% per annum. Earnings is forecast to decline by 51% per annum over the same time period.
Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year.
Reported Earnings • Mar 11Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €11.36 (up from €9.88 loss in FY 2020). Revenue: €3.21b (up 32% from FY 2020). Net income: €2.17b (up €4.06b from FY 2020). Profit margin: 68% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Revenue exceeded analyst estimates by 2.3%. Earnings per share (EPS) also surpassed analyst estimates by 31%. Over the next year, revenue is forecast to grow 28%, compared to a 4.8% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 12% per year.
Price Target Changed • Mar 08Price target increased to €18.92Up from €17.59, the current price target is an average from 17 analysts. New target price is 19% below last closing price of €23.30. Stock is up 135% over the past year. The company is forecast to post earnings per share of €11.83 next year compared to a net loss per share of €9.88 last year.
Buying Opportunity • Feb 22Now 21% undervaluedOver the last 90 days, the stock is up 24%. The fair value is estimated to be €24.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 24% per annum over the last 3 years. The company has become profitable over the last year.
Price Target Changed • Nov 17Price target increased to €15.32Up from €14.27, the current price target is an average from 18 analysts. New target price is approximately in line with last closing price of €14.65. Stock is up 112% over the past year. The company is forecast to post earnings per share of €8.75 next year compared to a net loss per share of €9.88 last year.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS €6.64 (vs €10.26 loss in 3Q 2020)Third quarter 2021 results: Revenue: €746.3m (down 9.2% from 3Q 2020). Net income: €1.27b (up €3.23b from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Price Target Changed • Sep 20Price target increased to €12.75Up from €11.88, the current price target is an average from 17 analysts. New target price is approximately in line with last closing price of €12.82. Stock is up 142% over the past year.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS €0.78 (vs €0.019 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €664.2m (up 13% from 2Q 2020). Net income: €149.9m (up €153.6m from 2Q 2020). Profit margin: 23% (up from net loss in 2Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance.
Price Target Changed • Aug 04Price target increased to €11.88Up from €11.02, the current price target is an average from 15 analysts. New target price is approximately in line with last closing price of €12.32. Stock is up 95% over the past year.
Price Target Changed • Jul 21Price target increased to €11.63Up from €10.85, the current price target is an average from 16 analysts. New target price is approximately in line with last closing price of €11.89. Stock is up 92% over the past year.
Price Target Changed • Jun 15Price target increased to €10.86Up from €10.13, the current price target is an average from 16 analysts. New target price is 9.5% below last closing price of €12.00. Stock is up 85% over the past year.
Reported Earnings • May 14First quarter 2021 earnings released: EPS €1.13 (vs €0.33 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €733.3m (up 13% from 1Q 2020). Net income: €215.7m (up €278.9m from 1Q 2020). Profit margin: 29% (up from net loss in 1Q 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 105 percentage points per year, which is a significant difference in performance.
Price Target Changed • May 12Price target increased to €9.44Up from €8.80, the current price target is an average from 16 analysts. New target price is 8.2% below last closing price of €10.28. Stock is up 95% over the past year.
Price Target Changed • Mar 20Price target decreased to €8.60Down from €9.33, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 54% over the past year.
Price Target Changed • Mar 18Price target decreased to €8.49Down from €9.13, the current price target is an average from 14 analysts. New target price is approximately in line with last closing price of €8.55. Stock is up 46% over the past year.
Is New 90 Day High Low • Jan 05New 90-day high: €8.44The company is up 18% from its price of €7.15 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €4.57 per share.
Is New 90 Day High Low • Nov 25New 90-day high: €7.25The company is up 14% from its price of €6.38 on 26 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.76 per share.
Reported Earnings • Nov 13Third quarter 2020 earnings released: €10.26 loss per shareThe company reported a poor third quarter result with increased losses and weaker revenues and control over expenses. Third quarter 2020 results: Revenue: €821.7m (down 9.2% from 3Q 2019). Net loss: €1.96b (loss widened €1.91b from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 132% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Nov 13Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 1.4%. Earnings per share (EPS) exceeded analyst estimates by 3,169%. Over the next year, revenue is forecast to grow 3.2%, compared to a 3.6% growth forecast for the Chemicals industry in Germany.
Price Target Changed • Oct 06Price target raised to €8.30Up from €7.58, the current price target is an average from 20 analysts. The new target price is 18% above the current share price of €7.04. As of last close, the stock is down 42% over the past year.
Is New 90 Day High Low • Sep 22New 90-day low: €5.29The company is down 9.0% from its price of €5.80 on 24 June 2020. The German market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.99 per share.